Page last updated: 2024-11-02

phenylbutazone and Postgastrectomy Syndromes

phenylbutazone has been researched along with Postgastrectomy Syndromes in 1 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Postgastrectomy Syndromes: Sequelae of gastrectomy from the second week after operation on. Include recurrent or anastomotic ulcer, postprandial syndromes (DUMPING SYNDROME and late postprandial hypoglycemia), disordered bowel action, and nutritional deficiencies.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Labrid, C1
Dureng, G1
Delort, P1
Chopard, M1
Courcy, J1

Other Studies

1 other study available for phenylbutazone and Postgastrectomy Syndromes

ArticleYear
Activity of a lyophilised whole extract of lamb gastric mucosa in several experimental models of digestive pathology in the rat, the dog and the monkey.
    Arzneimittel-Forschung, 1977, Volume: 27, Issue:4

    Topics: Animals; Body Weight; Diarrhea; Dogs; Female; Gastric Mucosa; Gastrointestinal Diseases; Haplorhini;

1977